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The receptor for advanced glycation endproducts (RAGE) is a
pattern-recognition receptor that binds to diverse ligands and
initiates a downstream proinflammatory signaling cascade.
RAGE activation has been linked to diabetic complications,
Alzheimer disease, infections, and cancers. RAGE is known to
mediate cell signaling and downstream proinflammatory gene
transcription activation, although the precise mechanism sur-
rounding receptor-ligand interactions is still being elucidated.
Recent fluorescence resonance energy transfer evidence indi-
cates that RAGEmay formoligomers on the cell surface and that
this could be related to signal transduction. To investigate
whether RAGE forms oligomers, protein-protein interaction
assays were carried out. Here, we demonstrate the interaction
betweenRAGEmolecules via their N-terminal V domain, which
is an important region involved in ligand recognition. Byprotein
cross-linking using water-soluble and membrane-impermeable
cross-linker bis(sulfosuccinimidyl) suberate andnondenaturing
gels, we show that RAGE forms homodimers at the plasma
membrane, a process potentiated by S100B and advanced glyca-
tion end products. Soluble RAGE, the RAGE inhibitor, is also
capable of binding to RAGE, similar to V peptide, as shown by
surface plasmon resonance. Incubation of cells with soluble
RAGE or RAGE V domain peptide inhibits RAGE dimerization,
subsequent phosphorylation of intracellular MAPK proteins,
and activation of NF-B pathways. Thus, the data indicate that
dimerization of RAGE represents an important component of
RAGE-mediated cell signaling.
The receptor for advanced glycation end products (RAGE)2
was first cloned as an AGE-binding protein (1), but it is now
evident that this so-called pattern-recognition receptor also
binds tomultiple ligands, including S100 proteins, amphoterin/
highmobility group box-1, amyloid-, andMac-1 (2–5). RAGE
is expressed in a wide range of tissues, such as brain, kidney,
liver, heart, and the vasculature, and in diverse cell types,
including smooth muscle cells, endothelium, T-lymphocytes,
neurons, and monocytes/macrophages (6). The receptor may
have a homeostatic role as a component of the innate immune
response (7). Overexpression of RAGE and downstream proin-
flammatory signaling upon ligand binding are associated with
several disease states such as diabetic complications, Alzheimer
disease, cancer, and viral infections (4, 7–11). Soluble RAGE
(sRAGE), which is composed of the extracellular domains but
lacks the transmembrane and cytosolic domains, is produced
by both proteolytic cleavage of RAGE and alternative mRNA
splicing (12, 13). Soluble RAGEmay act as a dominant negative
isoform and block RAGE signaling by functioning as an extra-
cellular “decoy receptor” to inhibit RAGE ligand binding (14).
The human RAGE gene (or AGER) is located on chromo-
some 6 in themajor histocompatibility complex class III region
that contains 11 exons. RAGE consists of 404 amino acids with
a molecular mass of 45–55 kDa, which can be variable depend-
ing on differential glycosylation states (1). Structurally, RAGE
belongs to the immunoglobulin superfamily, and the protein
consists of an N-terminal signal peptide (amino acids 1–22), a
V-type immunoglobulin-like domain (amino acids 23–116),
two tandem C-type immunoglobulin-like domains (amino
acids 124–221 and 227–317, respectively), a single transmem-
brane domain (amino acids 343–363), and a short C-terminal
intracellular cytoplasmic tail (amino acids 364–404) (1). The V
domain is the binding site for AGEs that interact with RAGE at
the micromolar level (9), although other domains also play a
role in ligand binding. For example, S100B binds to both the V
and C1 domains, whereas S100A6 binds to C1 and C2 domains
(15). It was reported recently that the V andC1 domains are not
independent, but rather form an integrated structural unit for
ligand recognition (16).
The cytoplasmic tail is essential for RAGE-mediated cell sig-
naling, although this sequence has no homology to any known
protein-tyrosine or serine/threonine kinase motif. Recent evi-
dence using a yeast two-hybrid approach suggests that the
RAGE cytoplasmic domain interacts with diaphanous-1 (Dia-
1), and this potential binding partner could constitute the basis
for intracellular signaling (17). RAGE-ligand binding results in
phosphorylation of various protein kinases involving MAPKs,
Rac/Cdc42, and Janus kinase (JAK)/signal transducers and acti-
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vator of trannscriptions (STATs) and subsequently activates
the NF-B pathway, which can be attenuated by the extracellu-
lar domain of RAGE (18–23). Such signal transduction path-
ways link RAGE to a number of inflammation-related cell
responses, such as apoptosis, mobility, migration, and proin-
flammatory gene expression (24). Thus, RAGE has been the
focus for a number of smallmolecule drugs or neutralizing anti-
bodies that can regulate ligand binding or downstream signal
transduction and thereby prevent disease (24, 25).
Most RAGE ligands, including S100B and amyloid , func-
tion as oligomers (26, 27). A recent study using in-cell fluores-
cence resonance energy transfer (FRET) has demonstrated that
RAGE forms oligomers at the plasma membrane (28). This
property may be necessary for AGE ligand recognition and sig-
nal transduction, albeit in a manner dissimilar from the well
characterized phosphotyrosine kinase receptors for many
growth factors and cytokines (29). It has been shown that bac-
terially expressed sRAGE form tetramers in vitro (30), but to
date, very little experimental evidence has been provided to
identify the oligomerization of RAGE on the cell surface. This
study sought to determine the nature of RAGE oligomerization
and whether this property is altered by ligand binding and
required for downstream signaling. Our findings add to under-
standing the molecular nature of RAGE and highlight possibil-
ities for novel intervention strategies.
EXPERIMENTAL PROCEDURES
Cell Culture, Treatments, and Transfections—HEK293T
cells from the American Type Culture Collection (ATCC) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen) supplemented with 10% fetal calf serum (FCS) and
100 g/ml PrimocinTM and were maintained in a humidified
incubator containing 5% CO2 at 37 °C. Approximately 1 106
HEK293T cells were plated in each well of a 6-well plate in 10%
FCS/DMEM for 24 h. Cells were then cultured in 1% FCS/
DMEM for another 24 h followed by S100B or AGE-BSA
treatment.
For transfection of plasmids in HEK293T cells, 3 106 cells
were plated on 100-mmPetri dishes at 24 h before transfection.
DNA-Lipofectamine 2000 complex was prepared by mixing 1
ml of Opti-MEM I reduced serum medium containing HA-
RAGE and GFP-RAGE plasmids (4g each) with 1ml contain-
ing 30l of Lipofectamine 2000 (Invitrogen) and incubating the
mixture at room temperature for 20 min. DNA-Lipofectamine
2000 complex was added to the wells containing cells and 10%
FCS/DMEM. 24 h post-transfection, cells were harvested for
immunoprecipitation or cultured for another 24 h in 1% FCS/
DMEM followed by S100B or AGE-BSA for further analysis.
Plasmids—Full-length of RAGE cDNAwas isolated from the
human retinal Mu¨ller glial cell line (MIO-M1; a kind gift from
Dr. Astrid Limb, Institute of Ophthalmology, University Col-
lege London, UK) using primers 5-AAGGAATTCATGGCAG-
CCGGAACAGCAGTTGGAGC-3 and 5-ATTCTCGAGTC-
AAGGCCCTCCAGTACTACTCTC-3 and inserted into
EcoRI/XhoI restriction sites of pcDNA3-GFP, pcDNA3-HA,
pGEX-4T-1 vectors. RAGE deletions, which were termed as
NM (amino acids 1–363, sense primer 5-AAGGAATTCAT-
GGCAGCCGGAACAGCAGTTGGAGC-3 and antisense
primer 5-AGTCTCGAGTTACTTCCCAGGAATCTGG-
TAGACAC-3), CM (amino acids 318–404, sense primer
5-CTAGAATTCATCAGCATCATCGAACCAGGCG-3 and
antisense primer 5-ATTCTCGAGTCAAGGCCCTCCA-
GTACTACTCTC-3), V (amino acids 1–123, sense prim-
er 5-AAGGAATTCATGGCAGCCGGAACAGCAGTTGG-
AGC-3 and antisense primer 5-AGTCTCGAGTTACTTCCC-
AGGAATCTGGTAGACAC-3), C (amino acids 124–342,
sense primer 5-GCCGAATTCCCAGAAATTGTAGATTCTG-
CCTC-3 and antisense primer 5-ATTCTCGAGTTAGGCTA-
GAGTTCCCAGCCCTGATC-3), C1 (amino acids 124–226,
sense primer 5-GCCGAATTCCCAGAAATTGTAGATTC-
TGCCTC-3 and antisense primer: 5-ATTCTCGAGTT-
ACTGGATGGGGGCTGTGCGCAAG-3), C2 (amino acids
227–342, sense primer 5-ATAGAATTCCCCCGTGTCTGG-
GAGCCTGT-3 and antisense primer 5-ATTCTCGAGTTA-
GGCTAGAGTTCCCAGCCCTGATC-3), were PCR-ampli-
fied, and subcloned into EcoRI/XhoI restriction sites of
pcDNA3-GFP, pcDNA3-HA, and pGEX-4T-1 vectors. For
RAGE cysteine mutants, cysteine at amino acids 38, 99, 144,
208, 259, or 301 was mutated to alanine individually by site-
directed point mutagenesis and subcloned into pcDNA3-HA
vector. The cis-reporter plasmid pNFKB-Luc (Stratagene)
encodes a Photinus pyralis (firefly) luciferase under a regular
TATA box and an enhancer element with a synthetic promoter
of five tandem NF-B-binding sites. The pRL plasmid (Pro-
mega) contains a Renilla reniformis (Renilla) luciferase cDNA
under the control human cytomegalovirus promoter.
Immunofluorescence—HEK293T cells were plated onto cov-
erslips in a 6-well plate. Cells were fixed in 4% paraformalde-
hyde for 1 h at room temperature followed by permeabilization
using 0.2% Triton X-100, 5% BSA/PBS for 5 min on ice. The
coverslips were then blocked in 5% BSA/PBS for 1 h at room
temperature. After a brief washing, the coverslips were incu-
bated with mouse monoclonal anti-RAGE antibody (1:1000)
(Millipore) at 4 °C overnight, washed, and incubatedwithAlexa
Fluor 488 goat anti-mouse IgG (1:500) (Invitrogen) in a dark
chamber for 1 h at room temperature. After extensive washing,
the coverslips were inverted and mounted on slides with
Vectashield mounting medium with 4,6-diamidino-2-phe-
nylindole (Vector Laboratories). The immunofluorescence was
assessed using Nikon TE-2000 confocal microscopy.
Preparation of AGEs—AGE-modified albumin was prepared
as described previously (31). 50mg/ml BSAwas incubated with
0.5 M of D-glucose in 0.2 M PBS, pH 7.4, at 37 °C for 60 days.
Control albumin was incubated for a comparable time in PBS
alone. AGEs were dialyzed in 0.2 M sodium phosphate buffer,
pH 7.4, and were passed through a Detoxi-Gel endotoxin
removing column (Pierce). The protein concentration was
determined using BCA quantification kit (Pierce).
Western Blotting and Immunoprecipitation—HEK293T cells
maintained in 1% FCS/DMEM were treated with the indicated
amount of S100B or AGE-BSA for 30 min. Cell lysates were
prepared with RIPA buffer (50 mM TrisHCl, pH 7.5, 150 mM
NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, 5 mM -glyc-
erophosphate, 1mMNa3VO4, 1mMNaF, 1 protease inhibitor
mixture) on ice for 30 min. 20 g of the total protein was
applied to a 10% SDS-PAGE and blotted to an Immobilon-FL
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polyvinylidene difluoride membrane (Millipore). Quantitative
Western blotting was performed using Odyssey infrared imag-
ing system (Li-COR), which allows detection of two proteins
simultaneously by using fluorescently labeled antibodies and
quantification of proteins more accurately over a much wider
linear dynamic range than chemiluminescence by using near-
infrared fluorescence detection (32). Briefly, the Immobilon-FL
polyvinylidene difluoride membrane was incubated with rabbit
monoclonal anti-p44/42 (1:1000) or p-p44/42 (1:1000) anti-
body (Cell Signaling Technology) together with mouse mono-
clonal -actin antibody (1:20,000,
Sigma) at 4 °C overnight followed by
incubation with IRDye 680 goat
anti-rabbit and IRDye 800CW goat
anti-mouse secondary antibodies
(1:10,000) (Li-COR) at room tem-
perature for 30min. Themembrane
was then scanned, and the bands
were quantified using the Odyssey
imaging system.
For immunoprecipitation,
HEK293T cells were transfected
with GFP-RAGE and HA-RAGE or
pcDNA3-HA vector, treated with
RAGE ligands as aforementioned,
and lysed in RIPA buffer. 500 g of
the total cell lysates were precleared
with protein A/G Plus beads (Santa
Cruz Biotechnology) for 1 h at 4 °C
and then incubated with anti-HA
antibody (Roche Applied Science)
and protein A/G Plus beads over-
night at 4 °C. The beads were exten-
sively washed, eluted by boiling in
SDS protein sample buffer, and sub-
jected to SDS-PAGE and Western
blotting.
Protein Purification, Cleavage,
and GST Pulldown—pGEX-4T-1-
RAGE, pGEX-4T-1-sRAGE, and
pGEX-4T-1-V were transformed
into BL21 Escherichia coli. Trans-
formed E. coli cells were induced by
0.2 mM isopropyl 1-thio--D-galac-
topyranoside for 4 h at 37 °C. Cells
were harvested and lysed in BufferA
(25 mM TrisHCl, pH 8.0, 1 mg/ml
lysozyme, 1mg/mlDNase I, 100mM
NaCl, 1mMDTT, 1mMPMSF). The
pellet was collected by centrifuga-
tion and washed with Buffer B (25
mM TrisHCl, pH 8.0, 100 mMNaCl,
1 mM DTT, 1 mM PMSF, 1% Triton
X-100) and Buffer C (25 mM
TrisHCl, pH 8.0, 100 mM NaCl, 1
mM DTT, 1 mM PMSF, 2 M urea).
The pellet was then resuspended in
Buffer D (50 mM TrisHCl, pH 8.0,
10 mMDTT, 8 M urea). The aqueous fraction was dialyzed with
gradient urea buffer (25 mM TrisHCl, pH 8.0, 100 mM NaCl, 1
mM DTT supplemented with 6, 4, 3, 2, 1, 0 M of urea, respec-
tively). The dialyzed samples were centrifuged, and the GST
fusion proteins in the supernatants were purified with
MagneGST beads (Promega) according to the manufacturer’s
instructions. Purified proteins were cleaved as required using
Thrombin CleanCleave kit (Sigma) according to the manual.
Cleaved GST tag was cleared from the protein samples by
MagneGST beads.
FIGURE 1. RAGE-activatedMAPK pathways in HEK293T cells. A, 4% paraformaldehyde-fixed HEK293T cells
were evaluated for RAGE immunolocalization using an anti-RAGE monoclonal antibody (Ab) (green). The cell
nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) (blue). S, signal peptide; V, IgV-like domain;
C, IgC-like domain; M, transmembrane region; T, cytosolic tail. B, HEK293T cells were transfected with 20 nM
scrambled or RAGE-specific siRNA. 48 h post-transfection, cells were lysed and subjected to Western blotting
for RAGE. C, HEK293T cells were cultured in 1% FCS/DMEM for 24 h followed by treatment with the indicated
amounts of S100B or AGE-BSA for 30min.Western blotting for total and phosphorylated p44/42,MEK1/2, p38,
JNK, p90RSK, Akt, and -actin was performed using 20 g of the whole cell lysates. D, HEK293T cells were
cultured in 1% FCS/DMEM for 24 h followed by treatment with 10g/ml S100B or 200g/ml AGE-BSA for the
indicated time. Phosphorylated or total p44/42 andMEK1/2 was probed using 20g of the whole cell lysates.
E,HEK293T cells were transfectedwith 20 nM of scrambled or RAGE-specific siRNA. 24 h post-transfection, cells
were grown in 1% FCS/DMEM for another 24 h and then treated with 10 g/ml S100B or 200 g/ml AGE-BSA
for 30 min. Phosphorylation of p44/42 and MEK1/2 was detected using 20 g of the whole cell lysates.
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HEK293T cells were transfected with a GFP-RAGE expres-
sion plasmid in 100-mm Petri dishes. 24 h after transfection,
cell lysates were prepared with RIPA buffer and incubated with
GST-fused RAGE, sRAGE, or V peptide, which had been pre-
immobilized to glutathione-Sepharose 4B beads. The protein-
bound beads were extensively washed and then eluted in SDS
protein sample buffer at 95 °C for 5 min. The eluates were
loaded onto an SDS-polyacrylamide gel.
Protein Cross-linking—Protein cross-linking using bis(sulfo-
succinimidyl) suberate (BS3) was performed according to the
manufacturer’s manual. Briefly, HEK293T cells were harvested
in PBS at a density of 2 107 cells/ml, washed three times with
ice-cold PBS, and then incubated with 4 mM BS3 for 30 min at
room temperature. The reaction was terminated by adding 20
mM TrisHCl, pH 7.5, for 15 min at room temperature. Cells
were then lysed in RIPA buffer, and Western blotting was per-
formed by loading 20 g of the whole cell lysates on an 8%
SDS-polyacrylamide gel.
Nondenaturing PAGE—Native gels containing 8% acrylam-
ide were prepared in 0.375 M TrisHCl, pH 8.8, without SDS.
The cell lysates were mixed with 5 native gel sample buffer
(312.5 mM TrisHCl, pH 6.8, 0.05% bromphenol blue, 10% glyc-
erol). The gel loaded with 20 g of the total protein was run in
native PAGEbuffer (25mMTrisHCl, 192mMglycine). Proteins
were then transferred to an Immobilon-FL polyvinylidene
difluoride membrane. Western blotting was performed as
described above.
Surface Plasmon Resonance—Pro-
tein binding interactions were per-
formed using a surface plasmon
resonance (SPR) Biacore Q system
(Biacore) as described previously (15)
with minor modifications. GST and
GST-RAGE were immobilized onto
distinct flow cells on the surface of
CM5 chips (Biacore) via amine cou-
pling with the carboxyl groups of the
chip dextran surface activated with
1:1 (v/v) solution of 0.2 M 1-ethyl-3-
(3-dimethylaminopropyl)carbodiim-
ide hydrochloride and 50 mM N-hy-
droxysuccinimide for 7 min at a flow
rate of 5l/min. 75l of protein to be
immobilized (50 g/ml) in sodium
acetatebuffer, pH4.5,was applied at a
flow rate of 5l/min.Unreacted ester
groupswereblockedbya7-min injec-
tion of 1.0 M ethanolamine hydro-
chloride solution (35 l). 11,000 RU
were obtained with GST, and 6545
RU were obtained for GST-RAGE.
For thestudyofprotein-protein inter-
actions, RAGE, sRAGE, and V pep-
tidewere diluted in 50mMTris buffer
(0.15 M NaCl, 5 mM CaCl2, 0.005%
(v/v) P20, pH7.5) from0.2 to 12.8M.
SPR sample run conditions consisted
of a cycle length of 5 min with a flow
rate of 10 l/min. At the end of each cycle, the chip surface was
regenerated using 50 mM NaOH (10 l, 30 s). Measurements of
protein interactionswereobtained fromresultingSPRsensograms
and expressed in terms of observed binding to immobilized pro-
teins as measured by arbitrary resonance units (RU).
NF-BLuciferaseAssay—HEK293Tcells (3104cellsperwell
in 24-well plates) were incubated in 2% FCS-supplemented
DMEMfor24hprior to transfection.Cellsweremock-transfected
or co-transfected with 2 g of cytomegalovirus-driven Renilla
luciferase plasmid (pRL) and 200 g of pGL3 basic vector (Pro-
mega) or pNFKB-Luc. 24 h post-transfection, cells were treated
with 10g/ml S100B for another 24 h. Cells were lysed in Passive
Lysis Buffer (Promega) and subjected to Dual-Luciferase assay
(Promega) followed by quantification using a Microlumat Plus
LB96V luminometer (Berthold).To investigateRAGEblockadeby
sRAGE and V peptide, cells were incubated with purified GST-
tagged sRAGE or V peptide at 24 h post-transfection. 10 g/ml
S100Bwas added to themediumcontaining the recombinantpep-
tides. In parallel, cells were cultured in fresh medium to remove
the free peptides in the previousmediumbefore S100B treatment.
24 h after S100B treatment, cells were lysed in Passive Lysis Buffer
and subjected to Dual-Luciferase assay.
RESULTS
RAGE Activates MAPK Signaling Pathways in HEK293T
Cells—Immunofluorescence and Western blotting analysis
demonstrated that RAGE is expressed inHEK293T cells, which
FIGURE 2. RAGE interacts with itself in cells and in vitro. A, HEK293T cells were co-transfected with GFP-
RAGE and HA-RAGE or pcDNA3-HA vector. 24 h post-transfection, cells were grown in 1% FCS/DMEM and
treated with 10 g/ml S100B or 200 g/ml AGE-BSA for 30 min. Cells were then lysed in RIPA buffer and
subjected to immunoprecipitation (IP) using anti-HA antibody. The immunoprecipitates were probed
with anti-GFP (green bands) and anti-RAGE antibodies (red bands).WCL, whole cell lysate. B, quantitation of
the interaction betweenHA-RAGE andGFP-RAGE as shown in A byOdyssey infrared imaging system. *, p
0.05; **, p 0.01 for S100B or AGE-treated cells versus PBS-treated cells. Data are presented asmean S.E.
of triplicate experiments. Neg., negative. C, GST-RAGE or GST control protein was expressed in E. coli,
purified, immobilized onto glutathione-Sepharose 4B beads, and incubated with the cell lysates obtained
from GFP-RAGE-transfected HEK293T cells. The proteins eluted from the beads were applied to Western
blotting with anti-GFP antibody (upper panel). Immobilized GST and GST-RAGE were stained with Coo-
massie Brilliant Blue R-250 (lower panel). D, quantitation of the interaction between GFP-RAGE and puri-
fied GST-RAGE as shown in C by Odyssey imaging system. *, p 0.05 for S100B or AGE-treated cells versus
PBS-treated cells. Data are mean  S.E. of triplicate experiments.
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is consistent with the finding that HEK293 cells react with S100
proteins (33). RAGE was localized to the plasma membrane of
the HEK293T cells (Fig. 1A), and the RAGE antibody recog-
nized four major bands withmolecular masses of 55, 50, and 45
kDa and a RAGE splicing form of 35 kDa, respectively (Fig. 1B).
The specificity of the RAGE immunoreactivity was demon-
strated by the absence or significant diminution of bands fol-
lowing transfection of HEK293T cells with RAGE-specific
siRNA (Fig. 1B).
In comparison with untreated cells, those treated with
increasing concentrations ofAGE-BSAor S100B demonstrated
a RAGE ligand-induced phosphorylation of various protein
kinases, including p44/42 (ERK1/2), MEK1/2, p38, JNK, and
p90RSK, in a dose-dependentmanner (Fig. 1C). In contrast, the
phosphorylation level of Akt remained unaltered by RAGE
ligand exposure (Fig. 1C). The increased phosphorylation of
p44/42 and MEK1/2 in S100B or AGE-BSA-treated HEK293T
cells was observed at 10 min and peaked at 1 h post-treatment
when comparedwith the basal phosphorylation levels of p44/42
and MEK1/2 in nontreated cells (Fig. 1D). Control (non-AGE-
modified) BSA produced no response (data not shown).
HEK293T cells were transfected with RAGE siRNA to deter-
mine whether S100B or AGE-BSA-induced activations of
MAPK pathways are RAGE-dependent. RAGE siRNA-
transfected HEK293T cells failed to show S100B and AGE-
BSA-induced phosphorylation of p44/42, whereas the cells
expressing the scrambled siRNA still showed the increased
phosphorylation of p44/42 (Fig. 1E).
RAGE VDomainMediates the Receptor Homo-interaction in
Cells or in Vitro—Fluorescence resonance energy transfer anal-
ysis of RAGE ligands has indicated that RAGE forms oligomers
(23). To further study this phenomenon, the RAGE cDNA was
subcloned into pcDNA3 vectors containing GFP orHA tag. GFP-
RAGE plasmid was co-transfected with pcDNA3-HA vector or
HA-RAGE plasmid. At 24 h post-transfection, cells were treated
with S100B or AGE-BSA, and co-immunoprecipitation was car-
ried out with anti-HA antibody and the whole cell lysates. GFP-
RAGEwas detected by both anti-GFP antibody (green bands) and
anti-RAGE antibody (red bands) in GFP-RAGE and HA-RAGE
co-transfected cells but was absent in GFP-RAGE and
pcDNA3-HAvector co-transfected cells (Fig. 2A). S100B orAGE-
BSA treatment further potentiated the binding of GFP-RAGE to
HA-RAGE (Fig. 2A). Quantification of the blots indicated that the
interaction between RAGE proteins was enhanced by nearly 50%
in the presence of 10 g/ml S100B or 200 g/ml AGE-BSA (Fig.
2B). To further examine the RAGE homo-interaction, RAGEwas
expressed as aGST fusion protein in E. coli, purified, immobilized
onglutathione-Sepharose4Bbeads, and incubatedwith the lysates
from GFP-RAGE-overexpressing HEK293T cells. GST-RAGE
was shown as double bands on SDS-polyacrylamide gel, which is a
common phenomenon for prokaryotically expressed GST fusion
proteins, includingGST-fused RAGEprotein (17), and is presum-
ably due to proteolysis of the expressed protein (34). GST pull-
down assay indicated that GFP-RAGE interacted with GST-
RAGE specifically but not GST control protein in vitro (Fig. 2C).
Similarly to the co-immunoprecipitation assay, the interaction
between GFP-RAGE and GST-RAGE was enhanced in the pres-
ence of S100B or AGE-BSA (Fig. 2,C andD).
To map the key region that mediates RAGE homo-interac-
tion, plasmids encoding different RAGE deletions were con-
structed with HA tag (Fig. 3A) and co-transfected with GFP-
RAGE in HEK293T cells. Co-immunoprecipitation revealed
that the deletions lacking the RAGEN-terminal V domainwere
incapable of binding toGFP-RAGE (Fig. 3B), indicating that the
V domain is indispensable for RAGE homo-interaction. Fur-
ther evidence for this was obtained from fluorescent micros-
copy of HEK293T cells that were transfected with GFP-tagged
V, C1, or C2 expression plasmid. It was shown that only the
RAGE deletion containing V domain was localized to the
plasma membrane, indicating the association of this peptide to
the cell surface RAGE, although by contrast RAGE C1 and C2
were expressed in the cell cytoplasm (Fig. 3C).
Endogenous RAGE Forms Homodimers at the Plasma
Membrane—To identify RAGEoligomers, HEK293T cells were
collected and treated with BS3, a water-soluble andmembrane-
impermeable cross-linker that is ideal for cross-linking of the
cell surface proteins. The whole cell lysates were then extracted
and subjected to Western blotting analysis. Monomeric RAGE
was detected at 55 kDa, although RAGE protein was also
FIGURE 3. RAGE V domain is essential for RAGE homo-interaction.
A, schematic representation of RAGE deletions. S, signal peptide; V, IgV-like
domain;C, IgC-like domain;M, transmembrane region; T, cytosolic tail.B,GFP-
RAGE plasmid was co-transfected with HA-tagged RAGE deletions into
HEK293T cells. The co-immunoprecipitation was performed using anti-HA
antibody. The immunoprecipitates (IP) were probed with anti-GFP antibody.
WCL, whole cell lysate. C, HEK293T cells were grown on coverslips and trans-
fected with GFP-tagged RAGE V, C1, or C2 expression plasmid. 24 h post-
transfection, cells were fixed and examined under a fluorescent microscope.
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observed at 110 kDa with some minor bands with higher
molecular masses. This suggests that RAGE exists as both
monomers and oligomers, although dimers appear to be the
dominant oligomeric formof this receptor (Fig. 4A). Consistent
with the protein interaction assays, treatment with 10 g/ml
S100B or 200 g/ml AGE-BSA prior to protein cross-linking
resulted in 50% enhancement of RAGE dimerization (Fig.
4B). As a parallel approach to investigate formation of RAGE
dimers, a band at 110 kDa was detected in nondenaturing
PAGE, and ligand treatment increased the band intensity (Fig.
4,C andD). The lysates fromGFP-RAGE-transfected cells were
also subjected to the nondenaturing PAGE. The GFP-RAGE
monomers at 80 kDa and homodimers at 160 kDa were
detected (Fig. 4E). Consistent with the previous results, S100B
and AGE-BSA treatments increased GFP-RAGE dimerization
compared with the control (Fig. 4E).
Soluble RAGE and RAGE V Pep-
tide Bind to RAGE—Because RAGE
homodimerization is mediated by
the RAGE V domain, we asked
whether sRAGE, which contains the
extracellular part of RAGE, could
bind to RAGE. The interaction of
sRAGE with full-length RAGE was
assayed by GST pulldown. GST-
fusedRAGE, sRAGE, andVpeptide,
as well as GST control protein, were
expressed in E. coli, purified, immo-
bilized on glutathione-Sepharose
4B beads, and incubated with the
cell lysates from GFP-RAGE-over-
expressing cells. As a result, GFP-
RAGE was pulled down by GST-
tagged RAGE, sRAGE, and V but
not GST control protein (Fig. 5A).
SPR experiments were carried
out to further analyze the binding
between RAGE molecules. GST-
RAGEwas immobilized onto aCM5
Biacore sensor chip. GST-tagged
RAGE, sRAGE, and V peptide were
cleaved by thrombin to remove the
GST tag (Fig. 5B). These peptides
were then injected over the flow
cells. The sensorgrams of the three
peptides showed a rapid increase of
RU indicating binding of these pep-
tides to the immobilized RAGE on
the chip followed by a decrease of
RU resulting from a loss of the
bound molecules upon washing
(Fig. 5C). Binding of the immobi-
lizedRAGE toRAGE, sRAGE, andV
peptide were concentration-depen-
dent (Fig. 5, C and D). RAGE,
sRAGE, and V peptide were also
injected over the flow cell on which
GST was immobilized as a negative
control. No binding was observed (RU 10, data not shown).
These results confirmed that RAGE is capable of binding to
another RAGE molecule, its soluble form, or the V peptide,
which harbors the key region mediating RAGE homo-
interaction.
Soluble RAGE and the Peptide of RAGE V Domain Block
RAGE Dimerization and Signaling—Because it has been
reported that both sRAGE and blockade of RAGE V domain by
the site-specific antibody can inhibit RAGE function (35), we
investigated if sRAGE or RAGEVpeptide inhibits dimerization
of the protein. HEK293T cells were incubatedwithGST-tagged
sRAGE or RAGEV peptide at 37 °C for 1 h before cell lysis. The
native gel indicated that RAGE dimerization was inhibited in
sRAGE or RAGE V peptide-treated cells compared with GST
control protein-treated cells (Fig. 6A). Both sRAGE and RAGE
V peptide inhibited S100B/RAGE-induced phosphorylation of
FIGURE 4. Endogenous RAGE forms homodimers at the plasmamembrane. A, HEK293T cells were treated
with PBS or 10g/ml S100B or 200g/ml AGE-BSA for 30min. About 2 107/ml of the cells were cross-linked
with 4mM BS3 for 30min at room temperature. The cross-linking was terminated by adding 20mM of TrisHCl.
20 g of the lysates from BS3-treated cells was probed with anti-RAGE antibody. B, quantitation of RAGE
dimerization as shown in A using Odyssey imaging system. **, p 0.01 for S100B or AGEs-treated cells versus
PBS-treated cells. Data are presented asmean S.E. of triplicate experiments.Neg., negative. C,HEK293T cells
were treated with PBS or 10 g/ml of S100B or 200 g/ml AGE-BSA for 30 min. The whole cell lysates were
applied to nondenaturing PAGE and probedwith anti-RAGE antibody.D, quantitation of RAGE dimerization as
shown in C using Odyssey imaging system. *, p  0.05; **, p  0.01 for S100B or AGEs-treated cells versus
PBS-treated cells. Data are presented as mean  S.E. of triplicate experiments. E, HEK293T cells were trans-
fected with GFP-RAGE expression plasmid. 24 h post-transfection, cells were cultured in 1% FCS/DMEM for
another 24 h. The whole cell lysates were subjected to nondenaturing PAGE and Western blotting using
anti-GFP antibody.
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FIGURE 5. Soluble RAGE andRAGEVpeptide bind to RAGE.A,GFP-RAGE overexpressing cell lysates were incubated with purified and immobilized GST,
GST-RAGE, GST-sRAGE, or GST-V peptide. The proteins bound to glutathione-Sepharose 4B beads were extensively washed and eluted by boiling in SDS
protein sample buffer. The eluates were applied to the Western blotting (WB) for GFP-RAGE using anti-GFP antibody (upper panel) and the immobilized
GST fusion proteins were stained with Coomassie Brilliant Blue R250 (lower panel). B, RAGE, sRAGE, and V peptide were purified from E. coli as GST fusion
proteins, followed by cleavage with thrombin to remove GST tag. Cleaved proteins (5 g) were loaded on a 15% SDS-polyacrylamide gel and staining
with Coomassie Brilliant Blue R-250. C, GST-RAGE (6545 RU) was directly immobilized onto the CM5 sensor chip. RAGE, sRAGE, or RAGE V peptide
(0.2–12.8 M) was injected over the flow cell at a flow rate of 10 l/min for 5 min for analysis of sensorgrams. D, binding abilities (RU) of RAGE, sRAGE,
and V to immobilized GST-RAGE assayed by SPR are shown as a bar chart. Data are means S.E. of triplicate injections.
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p44/42 MAPK (Fig. 6B), and a dose-dependent inhibition of
S100B/RAGE-induced p44/42 phosphorylation by RAGE V
peptide was observed (Fig. 6C).
Blockade of RAGE by Soluble RAGE or RAGE V Peptide
Attenuates NF-B Activation—It has been well documented
that ligand binding to RAGE leads to NF-B transcriptional
activation (19), a response that can be attenuated by the extra-
cellular domain of RAGE (ex-RAGE) (21). The inhibition of
MAPK pathway by sRAGE and V peptide suggested that the
NF-B pathway, which is responsible for the expression of
some proinflammatory cytokines in response to RAGE activa-
tion, might also be blocked. The NF-B reporter plasmid
pNFKB-Luc or pGL3 basic vector was co-transfected with pRL,
the control Renilla luciferase plasmid, into HEK293T cells to
evaluate the basal activity of NF-B in HEK293T cells. At 24 h
post-transfection, cells were treated with S100B for another
24 h. TheDual-Luciferase assay showed a relatively highNF-B
transcriptional activity in pNFKB-Luc-transfected HEK293T
cells compared with pGL3 basic vector-transfected cells
(5,000-fold) (p 0.001), which was increased by 2.1-fold fol-
lowing S100B exposure (p 0.01) (Fig. 7A). To investigate the
inhibitory effects of sRAGE andVpeptide onNF-B,HEK293T
cells carrying NF-B reporter plasmid were incubated with
purifiedGST-tagged sRAGE,Vpeptide, orGST control protein
for 1 h prior to the addition of S100B into the medium. Alter-
natively, cell culture medium was replaced with fresh medium
to remove free peptides before S100B treatment to prevent
competitive ligand binding. Comparedwithmock-treated cells,
GST did not affect the basal and
S100B/RAGE-induced NF-B activ-
ity. In the presence of sRAGE or V
peptide, the basal activity of NF-B
pathway was not obviously altered,
but S100B/RAGE-induced NF-
B activation was significantly
inhibited by 44 or 37%, respectively,
in contrast to GST-treated cells
(p  0.01). In the case that free
sRAGE or V peptide was removed
from the culturemedium after a 1-h
preincubation, S100B/RAGE-in-
duced NF-B activation was still
decreased by 29% (p 0.01) or 24%
(p  0.05), respectively, compared
with GST-treated cells (Fig. 7B). In
combinationwith the previous data,
these results indicate that S100B/
RAGE-induced NF-B activation
can be prevented by sRAGE and V
peptide not only through competi-
tive ligand binding but also through
other mechanisms, e.g. blockade of
intrinsic RAGE homodimerization.
DISCUSSION
RAGE iswidely expressed as a cell
surface glycoprotein in many cells
and tissues. Although the precise
nature of receptor-ligand interactions and downstream signal-
ing is still being elucidated, it is well known tomodulate impor-
tant proinflammatory responses (36, 37). Although the calcu-
lated molecular mass of RAGE is 42 kDa, the actual bands
detected by SDS-PAGE andWestern blotting are45, 50, and
55 kDa. The specificity of the bands detected by the RAGE
antibody was confirmed by combining an siRNA approach to
knock down RAGE in cells. The major band at 55 kDa may be
due to the post-translational modifications such as N-linked
glycosylation (38, 39), a common feature of cell surface recep-
tors. HEK293 cells were used as an in vitromodel because it has
been previously demonstrated that they react to S100 proteins
(33). We have also now demonstrated that they express consti-
tutive levels of RAGE. Exposure of HEK293T cells to the RAGE
ligands S100B and AGE-BSA induced the phosphorylation of
MEK1/2, p44/42, JNK, p38, and p90RSK, which is in common
withmany reported studies demonstrating RAGE-initiated sig-
naling, although the nature of these transduction cascades
evoked may differ between distinct cell types (24).
It is well established that S100B exists in oligomeric form,
including dimers and tetramers (26). Indeed, S100B tetramers
bind RAGE with higher affinity than dimeric S100B, and such
oligomersmay be able to induce dimerization of RAGE at the V
domain (26). Furthermore, a putative RAGE tetramer is
induced by the interaction with S100A12 hexamers (30). In this
study, a combination of co-immunoprecipitation, GST pull-
down, and SPR has demonstrated the interaction between
RAGE monomers via the V domain, which was further poten-
FIGURE6.SolubleRAGEandRAGEVpeptideblockRAGEdimerizationand subsequentMAPKactivation.
A,HEK293T cellswere incubatedwith 5g/mlGST, GST-sRAGE, orGST-Vpeptide for 1 hprior to treatmentwith
10g/ml S100B for 30min. Thewhole cell lysateswere subjected tonondenaturingPAGE, followedbyWestern
blotting for RAGE. B, HEK293T cells were incubated with 5 g/ml GST-sRAGE or GST-V peptide for 1 h prior to
treatmentwith10g/ml S100B for 30min. The cell lysateswere subjected toWesternblotting for-actin, total,
and phosphorylated p44/42. C, HEK293T cells were incubated with 5 g/ml GST or the indicated amount of
GST-V peptide (2–10 g/ml) for 1 h prior to treatment with 10 g/ml S100B for 30 min. Total and phosphor-
ylated p44/42 as well as -actin were detected by Western blotting using 20 g of the whole cell lysates.
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tiated by ligand binding. In nondenaturing gels and SDS-PAGE
loaded with cross-linked proteins, the predominant high
molecularmass receptor species is110 kDa, which represents
a dimeric fusion of RAGE monomers. Such dimerization
appears to occur constitutively, but upon exposure to RAGE
ligands, it is appreciably enhanced. It should be noted that
monomeric RAGE can also be detected in native gels and SDS-
PAGE separating extracts of plasma membrane cross-linked
proteins. This suggests that RAGEmay not function exclusively
in its dimeric form. In addition, some minor 110-kDa bands
were observed in cross-linked protein samples indicating that
RAGE might form oligomers or possibly even heterodimers
with other cell surface proteins, although precisely how this
regulates intracellular signaling remains uncertain.
Our study indicates that dimerization of RAGE is an impor-
tant step in receptor signaling following ligand binding, as
shown by MAPK phosphorylation and downstream transcrip-
tional activation. The mechanism for this remains to be identi-
fied, but it seems likely that dimerization offers the receptor a
better recognition of its ligands, especially if they also occur in
oligomeric configurations. Although RAGE C-terminal region
is not homologous to any known kinase domains, receptor
dimerization and its potentiation by ligand binding might have
an effect on the association of RAGE cytosolic tail to its inter-
acting proteins, e.g. Dia-1, to trigger signal transduction.
Various methods to block RAGE signaling have been
explored. Beyond the reported benefits of sRAGE acting as a
competitive inhibitor of receptor-ligand binding (14), proin-
flammatory pathology can be also inhibited by direct receptor
blockade with a RAGE V domain-specific antibody (40). Effi-
cacy of this antibody-based neutralization is through blockade
of the RAGE V domain and has been shown to attenuate amy-
loid--induced neuronal apoptosis (35).
Receptor homodimerization is important for signal trans-
duction of many receptor classes. For example, G protein-cou-
pled receptors not only formhomodimers but also bind to other
proteins, including receptors, ion channel, and chaperones
(41). Interference with this dimerization has been central to
the development of therapeutic small molecule inhibitors (42).
The current investigation has further explored the nature of
RAGE dimerization in response to ligand binding and identi-
fied the protein domains responsible. We have demonstrated
that inHEK293T cells, RAGE binding to S100B andAGEs leads
to enhanced dimer formation and that this is intimately linked
to signal transduction and transcriptional activation. RAGE
signaling and NF-B activation can be effectively attenuated by
preventing receptor dimerization using sRAGE and a RAGE V
peptide, both of which showed concentration-dependent bind-
ing to RAGE as determined by SPR. Removal of free sRAGE and
Vpeptide from the cell culturemediumafter preincubation still
revealed a decrease inNF-B transcriptional activity. This indi-
cates that sRAGE and V peptide might not only competitively
bind to RAGE ligand to exert their inhibitory effects but also act
in a more direct way to the endogenous RAGE, e.g. binding to
cell surface RAGE to block homodimerization. It cannot be
entirely excluded that that some V peptide may be released
from heterodimers of recombinant V peptide and endogenous
RAGE to block ligand binding. Nevertheless, the V domain has
been identified as central to RAGE dimerization. The use of
sRAGE or V peptide prevents normal function, not only by
acting as a decoy but also by direct blockade of the receptor
homo-interaction.
Taken together, our data suggest that RAGE functions as
homodimers on the plasma membrane, a phenomenon that
may contribute to ligand recognition and signal transduction.
Blockade of this mechanism could be an important strategy for
the regulation of RAGE-mediated proinflammatory signaling
in various disease states.
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